Risultati della ricerca

• 61. Lista Pubblicazioni dei componenti del Dipartimento - anno 2013 (22%)

  23-lug-2013 17.36.37

  in 8701-BC Breast Cancer Cells. Molecular carcinogenesis, 52, 348-358. - I.F.:3,164 - Scopus SJR:0,486 ... antisense oligonucleotides on gene expression of cadmium-treated MDA-MB231 breast cancer cells ... ). Proteomic profiling of Trastuzumab (Herceptin(R))-sensitive and -resistant SKBR-3 breast cancer ... in ERα(+) breast cancer cells. Oncogene, 32. - I.F.:6,373 - Scopus SJR:1,867 - SNIP:1,339 Barreca, S ... of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer. BMC Cancer, 13, 81-92

• 62. 91 bando 2023 (22%)

  12-dic-2023 8.50.08

  between breast TODARO Matilde 20223NY37M_001 LS4 B53D23021070006 1111 20/07/2023 cancer stem cells and ... TITLE Dissection of the dynamic interplay between breast cancer stem cells (BCSCs) and TME ... : obesity and breast cancer (BC). Obesity is escalating worldwide and it is estimated that nearly ... cancers, including breast, colorectal, pancreas, esophagus, endometrium. Indeed, overweight/obesity ... . The understanding of the molecular mechanisms governing breast CSC (BCSC)/tumor microenvironment (TME

• 63. 91 english version bando 2023 (22%)

  12-dic-2023 8.50.08

  /2023 pathogens after SARS-CoV-2 diffusion. Dissecting the dynamic interplay between breast ... TITLE Dissection of the dynamic interplay between breast cancer stem cells (BCSCs) and TME ... breast cancer (BC). Obesity is escalating worldwide and it is estimated that nearly a third ... breast, colorectal, pancreas, esophagus, endometrium. Indeed, overweight/obesity is one ... scientific hypothesis. The understanding of the molecular mechanisms governing breast CSC (BCSC)/tumor

• 64. Trial clinici (22%)

  27-lug-2023 10.48.43

  carrying harmful mutation in BRCA1 or BRCA2 gene are at higher risk to develop breast and/or ovarian cancer than the general population. Many observations lead to the hypothesis that breast cancer ... Trp53+/flox and K14Cre Brca1+/flox Trp53-/- mice) predisposed to develop hereditary breast cancer ... of humans; 2b) breast epithelial tissue in mice. Codice Clinical Trials: NCT03570125 Clinical Trials page ... (HER2-) advanced breast cancer patients The HERMIONE-7 trial Nord: Piacenza, Faenza (RA), Guastalla

• 65. Trial clinici (22%)

  25-lug-2023 12.34.14

  or BRCA2 gene are at higher risk to develop breast and/or ovarian cancer than the general population. Many observations lead to the hypothesis that breast cancer risk may be increased in women ... Trp53-/- mice) predisposed to develop hereditary breast cancer in response to corresponding dietary ... in: 2a) DNA samples from muscle biopsies of a subgroup of humans; 2b) breast epithelial tissue ... -Receptor-Positive (HR+), Human-Epidermal-Growth-factor-negative (HER2-) advanced breast cancer patients

• 66. 5255624 bando prin 2022 promise_en (22%)

  7-mag-2024 10.38.13

  /2023 pathogens after SARS-CoV-2 diffusion. Dissecting the dynamic interplay between breast ... TITLE Dissection of the dynamic interplay between breast cancer stem cells (BCSCs) and TME ... breast cancer (BC). Obesity is escalating worldwide and it is estimated that nearly a third ... breast, colorectal, pancreas, esophagus, endometrium. Indeed, overweight/obesity is one ... scientific hypothesis. The understanding of the molecular mechanisms governing breast CSC (BCSC)/tumor

• 67. 5255624 bando prin 2022 promise_it (22%)

  7-mag-2024 10.43.28

  between breast TODARO Matilde 20223NY37M_001 LS4 B53D23021070006 1111 20/07/2023 cancer stem cells and ... TITLE Dissection of the dynamic interplay between breast cancer stem cells (BCSCs) and TME ... : obesity and breast cancer (BC). Obesity is escalating worldwide and it is estimated that nearly ... cancers, including breast, colorectal, pancreas, esophagus, endometrium. Indeed, overweight/obesity ... . The understanding of the molecular mechanisms governing breast CSC (BCSC)/tumor microenvironment (TME

• 68. cv nicoletti (21%)

  16-gen-2018 14.47.25

• 69. Pubblicazioni STEBICEF anno 2018 - quartile q1, q2, q3, q4 (class. WOS) (21%)

  3-ott-2019 10.22.37

  in breast cancer 2018 Oncotarget q1 10.18632/oncotarget.25561 https://www.scopus.com/inward/record.uri ... expression is linked to breast cancer seeding and distant metastasis 2018 Breast Cancer Research q1

• 70. cv_neri (21%)

  31-mag-2023 11.02.32

  Breast Cancer Lesions Cancers 2022-06-14 | journal-article DOI: 10.3390/cancers14122922 Crossref Source ... on Digital Breast Tomosynthesis of BI-RADS Category 4 Calcifications Sent for Vacuum-Assisted Breast Biopsy ... : Determining the elastography strain ratio cut off value for differentiating benign from malignant breast ... of breast cancer: a Delphi consensus proposal 2022-01-01 | journal-article HANDLE: 11568/1133672 DOI ... European Radiology 2021-02-24 | journal-article DOI: 10.1007/s00330-020-07178-w Crossref Source: Breast

• 71. cv de placido (21%)

  24-apr-2020 8.00.43

  : 24 mesi. PRIN 2000: Identification and validation of new markers of the metastasizing breast ... Campania). Durata: 36 mesi. AIRC 2005: Breast Cancer: Preclinical and clinical development ... (Biobanca Oncologica Campania). Durata: 36 mesi. PRIN 2008: Breast cancers and hormone sensitivity: new ... of the head, neck and breast through the creation of a network of biobanks. PRIN 2015: Useful

• 72. pieghevole BIOTEC 2018 (21%)

  5-lug-2018 15.28.21

  miRNA shows oncogenic functions in triple recombinant collagenases. negative breast cancer. Walter ... approach of infertile patients. lividus sea urchin embryo. Gianluca Di Cara: 14-3-3 Proteins in breast ... prognostic factors in breast cancer: an in silico analysis. 11:30 -12:00 Coffee break ... of roots, stalks and rhizosphere modulation of cannabinoidergic system. variants on MDA-MB231 breast

• 73. REG_DID_CdLM_BCM_2015 approvato (20%)

  29-set-2015 10.48.46

  parthenolide in MDA-MB231 breast cancer cells. Carlisi D, Lauricella M, D'Anneo A, Buttitta G, Emanuele ... inhibits tumour growth and metastasis in a xenograft model of breast cancer. D'Anneo A, Carlisi D ... superoxide anion production by stimulating EGF receptor in MDA-MB-231 breast cancer cells. D'Anneo ... receptors in MDA-MB-231 breast cancer cells. Portanova P, Notaro A, Pellerito O, Sabella S, Giuliano M

• 74. 59 english version bando (20%)

  3-dic-2019 12.58.23

  fellowship grant: “The role of altered mechanotransduction in Breast Cancer metastatis”, to be carried out ... mechanotransduction in Breast Cancer metastatis” - Description: Breast cancer is the most frequent ... of metastatic breast cancer. Research in the last decade has solidified the notion that metastatic ... for metastatic breast cancer, and new criteria for disease classification and patient stratification

• 75. BIOLOGIA CELLULARE - Sconzo (20%)

  8-mar-2013 23.04.47

  caspase expression in MDA-MB231 breast cancer cells. Breast Cancer Res. Treat. 111, 461-474 (2008 ... breast cancer cells. Biochimie, 94, 207-213 (2012). 3. Librizzi M., Longo A., Chiarelli R., Amin J ... class I histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells. Chem. Res ... seguenti riviste Biological Procedures on line. International Journal of Breast Cancer. Journal

• 76. 2014_4485_bando RUSSO (20%)

  12-dic-2014 13.11.25

  ” -Title: “Molecular mechanisms involved in the response to treatment in women with breast cancer ... la maggior parte sono Triple Negative Breast Cancer (TNBC) per mancata espressione del recettore ... the genetic predisposition to the development of breast and ovarian cancer. The BRCA1/2 are the main ... , Basal-like. Among these, mosts are Triple Negative Breast Cancer (TNBC) for lack of expression ... lethality in BRCA1 mutated breast cancers. Durata mesi 12 - Fondi : economie di progetti

• 77. curriculum_STASSI_GIORGIO - web (20%)

  7-lug-2022 16.21.47

  della Salute “Ricerca Finalizzata”: Breast Cancer Stem Cells: innovative targeted terapie. Responsabile ... , Limite G, Petrella G, Condorelli G. PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer ... , Bertucci F, Stassi G., Dontu G, Birnbaum D, Wicha MS. Breast Cancer Cell Lines Contain Functional ... Breast Cancer. Clin Cancer Res. 2010 Jan 1;16(1):45-55. I.F. 6.2   34. Kemper K, Sprick MR ... and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol

• 78. D Anneo Antonella CV (20%)

  28-nov-2023 14.43.24

  2007). 2007-2013. Genome Breast cancer Xborder Risk Surveillance" (OP Italia-Malta Project, CCI ... by stimulating EGF receptor in MDA-MB-231 breast cancer cells. Int J Oncol. 43:1895- 900, 2013. 22 ... growth and metastasis in a xenograft model of breast cancer. Cell Death Dis.4:e891, 2013. 25. Di Fiore ... . The synergistic effect of SAHA and Parthenolide in MDA-MB231 breast cancer cells. J Cell Physiol. 230 ... positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI

• 79. CV Prof.ssa C. Gelfi (18%)

  7-apr-2020 10.20.26

  in breast cancer patients: a preliminary researchJ Exp Clin Cancer Res. 2013 Apr 30 De Palma S, Leone ... V, Viola M, Lupo C, Gelfi C, Messa C. Unmasking epithelial- mesenchymal transition in a breast ... , Gelfi C, Messa C (2012). Unmasking epithelial- mesenchymal transition in a breast cancer primary

• 80. Pubblicazioni STEBICEF anno 2017 - quartile q1, q2, q3, q4 (class. WOS) (18%)

  3-ott-2019 10.47.00

  breast cancer through SPIN1 regulation 2017 Oncotarget q1 10.18632/oncotarget.15960 https ... ., Luparello C. Molecular Signatures Associated with Treatment of Triple-Negative MDA-MB231 Breast ... Target in Triple-Negative Breast Cancers 2017 OMICS A Journal of Integrative Biology q1 10.1089/omi ... on breast cancer cells 2017 International Journal of Pharmaceutics q1 10.1016/j.ijpharm.2017.01.022 https